We examined the migratory properties of the mouse serum protein responsible for specific neutralization of the endogenous mouse xenotropic type C virus and demonstrated that this neutralizing factor can be transferred from mouse lipoproteins to human and to nonreactive mouse lipoproteins. After acceptance of this activity by these lipoproteins, it could be back-transferred to human and to mouse lipoproteins. This result was compatible with equilibrium binding of the responsible proteins by several classes of lipoproteins. The best expression of the transferred activity occurred with human chylomicrons. Small quantities of neutralizing factor which exist in free dispersion in serum were also detected by mixing the p > 1.21 g/ml density fraction of mouse serum with human chylomicrons; antiviral activity was subsequently found associated with the human lipoproteins. This result reflects the potentiation of antiviral activity of the protein in a lipoprotein environment. These observations offer a useful approach for the eventual purification and characterization of the neutralizing factor.
All strains of house mice contain inherited (endogenous) genes for a class of mouse type C viruses (MuLVs) which has an unusual host range. Although present in the genes of mice, these viruses are unable to reinfect mouse cells but have the capability of infecting cells of a wide variety of mammalian and avian species. This special characteristic of these viruses has been called xenotropism (7) . The xenotropic (Xtropic) viruses differ from the endogenous mouse ecotropic viruses, which are also inherited in the genes of many mouse strains but can reinfect mouse cells (8) . The ecotropic viruses have been associated with leukemia in mice. The role of the mouse X-tropic viruses is unknown.
We have identified lipoprotein (LP) classes normally found in mouse serum which specifically neutralize the mouse endogenous X-tropic type C virus. These LPs have no activity against the ecotropic class of endogenous MuLVs (6, 10) . The neutralizing activity was found primarily in the triglyceride-rich LPs (chylomicrons and very-low-density lipoproteins [VLDLs] ) and in the high-density lipoproteins (HDLs). Only very low titers have been found associated with lowdensity lipoproteins (LDLs) (4, 6) . Levels of this neutralizing factor (NF) are influenced by diet. Mice fed fat-enriched meals show high levels of NF in the triglyceride-rich LP and HDL fractions (4) . After fasting, this activity resides primarily in the HDLs. On the basis of these observations, we examined the possibility that a transfer of the factor responsible for neutralization could occur among mouse LPs. We demonstrated that NF could be transferred to a synthetic phospholipid-triglyceride emulsion (Intralipid) as well as to certain mouse LPs which had no antiviral activity (4) . Moreover, we found that extraction of the mouse LPs containing NF with 4.2 M tetramethylurea led to the recovery of antiviral activity in the tetramethylurea-soluble fraction. This activity was potentiated by association with lipid (4) . Since this active apolipoprotein preparation was sensitive to protease treatment, we concluded that NF resides among the non-B apolipoproteins of mice (4, 5) . Amphipathic lipids of mouse LPs also appear to have some antiviral effect which is general, since isolated mouse VLDL and its extracted lipids, but not mouse serum, have inactivated other MuLVs as well as X-tropic viruses (12) . This latter effect could result from a disruption of ordered lipids on the virus coat and could be involved in the enhanced activity of the anti-X-tropic virus apolipoprotein when mixed with lipid (4) . In this report, the migratory properties of NF, which has specific activity against the X-tropic MuLVs, are studied. We also examined the nature (6, 10) . The ability of the preparations to inhibit focus formation by the NZB MuLV pseudotype of murine sarcoma virus in normal rat kidney cells or by the C57L X-tropic MuLV in mink S+L-cells was used for the assay (1, 13) . In brief, 0.1 ml of infectious virus and 0.1 ml of samples to be tested were mixed at room temperature for 30 min. The mixture was then diluted 10-fold and assayed in tissue culture. That dilution which produced at least a 50% suppression of foci was considered the end titer of the preparation. Serial 10-fold dilutions of the serum were made to assess the titer of neutralizing activity. Subsequently, twofold dilutions were tested. Thus, by this biological assay, differences in serum titer of 25% could be appreciated. For neutralization studies of ecotropic (mouse-tropic) viruses, reduction of XC plaque formation in mouse embryo or NIH 3T3 cells was employed (14) . (2) . Antiserum to NF was prepared in a New Zealand white rabbit by hyperimmunization with high titers of (B6C3)Fl HDLs containing antiviral activity (4) . Preparation of LP fractions. LPs of the p < 1.006 g/ ml fractions were isolated from (B6C3)Fl and NFS mouse sera after a single ultracentrifugation at 38,000 rpm for 18 h in a 40.3 rotor in a Beckman model L ultracentrifuge after layering under 5 volumes of 0.15 M NaCl containing 1 mM EDTA, pH 8.6. The p > 1.006 g/ml fractions were adjusted to p = 1.063 g/ml with solid KBr-D20 and were centrifuged once at 38,000 rpm for 18 h. The p < 1.063 g/ml fractions were discarded, and the p > 1.063 g/ml fractions were adjusted to p = 1.21 g/ml with KBr-D20, again overlayed by 5 volumes of KBr-D20 solution. The HDLs in the density range of 1.063 < p < 1.21 g/ml were collected after a single centrifugation at 38,000 rpm for 18 h (4, 6).
Human chylomicrons were obtained from sera of patients with severe mixed lipemia in the p < 1.006 g/ ml fraction after centrifugation at 20,000 rpm for 20 min in a 40.3 rotor. Three milliliters of serum were layered in each tube under 6.5 ml of 0.15 M NaCl containing 0.5 mM EDTA, pH 8.6. The centrifugation was repeated once. Human LDLs were obtained from the density interval of 1.024 < p < 1.050 g/ml. Ultracentrifugation was repeated at the higher density limit.
Human HDLs were obtained from sera of normal female donors by ultracentrifugation between the density limits of 1.063 < p < 1.21 g/ml as described above. Centrifugation of the human HDLs was repeated at p = 1.21 g/ml. Gentamicin sulfate (10 ,ug/ml), sodium azide (0.5 mg/ml), and EDTA (0.4 mg/ml) were present in all ultracentrifugal media. All samples were dialyzed against 0.15 M NaCl, gentamicin sulfate (10 ,ug/ml), and EDTA (0.5 mM) before further studies were performed. Phospholipid concentrations of the LP fractions were measured in chloroform-methanol (2:1) extracts of the samples by the technique of Steward and Hendry (15) .
LP mixing experiments. Active (B6C3)F1 VLDLs were mixed with nonreactive NFS HDLs or human HDLs. Similarly, (B6C3)Fl HDLs with antiviral activity were mixed with inactive NFS VLDLs or human chylomicrons. The mixtures were incubated at 37°C for 1 h (at temperatures as high as 43°C, similar results were obtained). A 1/20 volume of 60% sucrose was then added to the samples to increase their density, and they were layered under 0.15 M NaCl containing gentamicin sulfate (10 Fg/ml) and EDTA (0.5 mM). The samples were centrifuged at 38,000 rpm for 18 h in a 40.3 rotor at 120C and separated into top and bottom fractions to be tested for the presence of NF. For back-transfer experiments, the reactive LPs were mixed again at 370C for 1 h with LPs not containing antiviral activity and then separated as described above.
Exchangeable apolipoproteins appear to be associated mostly with the surface monolayers of LPs. Since the phospholipid content of pseudomicellar LPs is proportionate to the LP surface area, we used this measurement to establish the relationships of the LP surface areas employed for these mixing experiments. In this manner, a relative index of the ability of various (Table  3A) . In a second group of experiments in which active mouse LPs were used, a back-transfer was observed when human chylomicrons were used as the recipient but not when human HDLs were employed (Table 3B ). This inability to transfer from NFS VLDLs to human HDLs is most likely due to the low activity present in the NFS VLDL sample. Alternatively, human HDLs may not potentiate the biological activity of NF as efficiently as human chylomicrons. The low activity that is recovered in these backtransfer experiments makes it difficult to evaluate fully these possibilities.
In a third set of studies, we attempted to transfer NF from active human LPs to mouse LPs. In several experiments, a slight transfer was achieved, but only when human chylomicrons with an NF titer of at least 100 were used for the transfer; the recipient mouse HDLs, undiluted, suppressed X-tropic virus infectivity by 50%. Active human HDLs at titers below 100 did not transfer detectable NF to mouse LPs. Finally, when we examined the back-transfer of NF from the active human LPs to unreactive human LPs, a transfer took place. However, this transfer also was only observed when human chylomicrons with a high titer of activity (>1,000) were employed. Human LPs with lower neutralizing activity could not transfer NF to other human LPs (Table 3C) .
These results indicate that a back-transfer of NF from active LPs to fresh nonreactive LPs can occur. The efficiency appears to be better with mouse LPs (e.g., mouse to human or mouse to mouse) than with human LPs (e.g., human to mouse or human to human LPs), but this observation probably reflects the larger total surface areas (higher concentrations) of the human LP preparations and the relative titers of NF employed in these experiments.
Comparison of transfer to mouse and human LPs. In view of the above results, we made a comparison of the abilities of mouse and human LPs to acquire and express neutralizing activity. Experiments were performed with equal areas of LP surface. For these studies, the content of phospholipid in both mouse and human LPs was measured (15) , and concentrations of the LPs being compared were mixed so as to provide identical ratios of phospholipid between HDLs and triglyceride-rich LPs in each case. Thus, the human chylomicrons and human HDLs used for this experiment were approximately three times and two times concentrated, respectively; mouse VLDLs and HDLs were prepared at seven-and fourfold concentrations, respectively. When constant amounts of active (B6C3)F1 VLDLs and HDLs were incubated with amounts of nonreactive human or NFS LPs which were equivalent to one another in surface area, human chylomicrons were the most efficient receptors or potentiators for NF (Table 4) . They were four times more efficient than the triglyceride-rich LPs from mice. This difference, however, may be due to the absence of chylomicrons in this mouse LP fraction. No substantial difference in the ability of the HDL fractions of NFS and humans to accept NF was observed. On the basis of these results, we have used human chylomicrons to enhance the activity of NF when it is removed from mouse LPs.
Neutralization of the NF activity transferred to mouse and human LPs. We wanted to demonstrate that mouse and human LPs, which received NF-like activity from active mouse LPs, contained the same moiety responsible for this antiviral activity associated with mouse LPs. We therefore mixed the mouse and human LPs containing NF with rabbit antisera made specifically against mouse LPs carrying NF (4). NZB serum served as a positive control. After 30 min at 37°C, we used these preparations in standard neutralization assays. The results showed elimination of the ability of the mouse and human LPs to neutralize the X-tropic virus (Table 5) . No anti-NF activity was observed with normal rabbit serum nor with goat serum directed against the principal human apoproteins (i.e., A, Bloo, B48, C, and E). These experiments confirmed that NF was transferred to the mouse and human LPs.
Presence of LP-free NF in serum. We have reported that the protein responsible for neutralization can be found in a very low titer circulating free of LPs in the sera of some (B6C3)F1 mice (4, 9) . In a further exploration of this observation, we took the p > 1.21 g/ml bottom fractions of sera from NFS and (B6C3)F1 mice who were fed a conventional diet. When the fraction was tested alone, no anti-X-tropic virus activity was detected, but after mixing this fraction with human chylomicrons, some neutralizing activity (1:10) specific for X-tropic virus was found associated with the human LPs. When we looked for this activity by a similar procedure in fat-fed NFS and (B6C3)F1 mice, none was detected. These results suggest that NF can exist in free dispersion in serum, but one effect of a high-fat diet is to adsorb this protein onto the circulating LPs which result from the fat-enriched meal.
Effect of NF on mouse ecotropic type C virus. For all of the experiments listed above, we monitored the effect of the LP fractions against the Moloney strain of ecotropic MuLV. No antiviral activity was noted in any of the sera or purified LPs at the concentrations used to inhibit X-tropic virus. These results are in contrast to those reported by other investigators (12) . It is probable that amphipathic lipids such as monoglycerides and certain phospholipids present in LPs have a nonspecific effect on envelope viruses. When we studied very concentrated LPs (>20-fold) from humans or mice, we too observed a limited inhibitory activity against ecotropic virus.
DISCUSSION
The results of these studies indicate that the apolipoprotein responsible for neutralization of X-tropic virus can be transferred from reactive mouse LPs to nonreactive mouse LPs and to human LPs. During this transfer, the activity is reduced somewhat but remains specific for Xtropic virus.
Among Our data provide further evidence that the protein responsible for neutralizing activity behaves like an apolipoprotein. It undergoes passive transfer among LP species and can exist in small amounts in dispersion, free of LPs, in the sera of mice (3) . The fact that NF is not found in the p > 1.21 g/ml plasma protein fraction of mice receiving a diet high in fat suggests that this protein binds to LPs which circulate in increased amounts after a fat-enriched meal. This behavior is consistent with the uptake of NF by chylomicrons from delipidated apolipoproteins of mice (4) .
Our studies also demonstrate that the distribution of this factor among mouse LPs shows an equilibrium behavior which is probably affected by both the amount of surface area of the species of LP presented to it and factors which specifically influence its binding efficiency. Our finding that this protein transfers readily to human LDLs is in contrast to the absence of NF activity associated with mouse LDLs. This observation suggests that there are important structural differences between the LDLs of these two species.
The migratory properties of NF demonstrated here should provide a useful approach toward the isolation and characterization of the responsible protein. Binding to artificial phospholipid-triglyceride emulsions may be an appropriate preliminary step in its separation from the other proteins of mouse HDLs. Furthermore, since NF has little activity in the absence of lipids, a sensitive assay method will be a critical requirement in the isolation of the protein from lipidfree mixtures of apolipoproteins. The enhancement of activity observed when NF is bound to human chylomicrons should provide the basis for such an assay.
